Search - tctmd.com

Displaying 81 - 100 of 215

Sort: Relevancy | Date

Presentation TVT 2022

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

Presenter: Maheedhar Gedela

June 10, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TCT 2021

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

Captis: Full-Body Embolic Protection Device

Presenter: Haim Danenberg

November 04, 2021

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation TCT 2021

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

Presenter: Dariusz Jagielak

November 04, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Presentation TCT 2020

TCT 635: Left Atrial Appendage Closure With Thrombus and Cerebral Protection Device

Presenter: Berenice Caneiro-Queija

October 14, 2020

Presentation TCT 2020

TCT 510: Contrast-free LVAD Outflow Intervention With Cerebral Protection

Presenter: Joshua Vogt

October 14, 2020

Advertisement

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Captis: Full-Body Embolic Protection Device

Cerebral Protection in TAVR: The PROTEMBO C Trial

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

TCT 635: Left Atrial Appendage Closure With Thrombus and Cerebral Protection Device

TCT 510: Contrast-free LVAD Outflow Intervention With Cerebral Protection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content